Mystery Patient Drill Toolkit

This toolkit is intended for use by hospital emergency departments, and tests how long it takes for a potential patient with a highly infectious disease to be identified and for staff to begin exposure mitigation procedures; how long it takes for a patient to be transferred to an isolation room; and the capability of the facility to make notifications internally and to the health department.

Infection control influence of Middle East respiratory syndrome coronavirus: A hospital-based analysis

During the study, the use of personal protective equipment after the occurrence of Middle East respiratory syndrome (MERS) infections compared with the period before MERS infections increased dramatically from 2,947.4 to 10,283.9 per 1,000 patient-days for surgical masks and from 22 to 232 per 1,000 patient-days for N95 masks.

Danger in the desert

Scientists investigated virus mutations and found that certain mutations made the Middle East respiratory (MERS) virus more resistant against the human immune system. The analysis of mutations is essential for predicting the risk of a pandemic.

Pool of MERS experts for deployment established by WHO’s Regional Office for the Eastern Mediterranean

Sixty high-level public health and Middle East respiratory syndrome (MERS) practitioners, researchers, and experts will meet to establish a pool of experts that can be deployed rapidly during any future outbreaks, as well as share and discuss the latest evidence, best practices, and lessons learned on MERS.

Atypical presentation of Middle East respiratory syndrome coronavirus in a Lebanese patient returning from Saudi Arabia

Around 2090 confirmed cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) from 27 countries have been reported to the World Health Organization (WHO) between September 2012 and October 2017, the majority of whom occurring in countries in the Arabian Peninsula, mainly in Saudi  Arabia.